Teva Pharmaceutical Industries Profit Margins 2006-2018 | TEVA

Current and historical gross, operating and net profit margins for Teva Pharmaceutical Industries (TEVA) over the last 10 years. The current net profit margin for Teva Pharmaceutical Industries (TEVA) as of March 31, 2018 is -72.36%.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.017B $22.385B
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $58.248B 10.24
Mylan (MYL) United Kingdom $18.315B 7.74
Dr Reddy's Laboratories (RDY) India $4.918B 29.37
Supernus Pharmaceuticals (SUPN) United States $2.842B 35.63
Akorn (AKRX) United States $2.188B 10.85
AxoGen (AXGN) United States $1.901B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.800B 3.03
Assembly Biosciences (ASMB) United States $0.860B 0.00
Homology Medicines (FIXX) United States $0.805B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.788B 73.48
Adamas Pharmaceuticals (ADMS) United States $0.731B 0.00
CymaBay Therapeutics (CBAY) United States $0.729B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.609B 0.00
Voyager Therapeutics (VYGR) United States $0.604B 0.00
Corium (CORI) United States $0.286B 0.00
Teligent (TLGT) United States $0.226B 0.00
Sol-Gel Technologies (SLGL) Israel $0.132B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.107B 0.00
Versartis (VSAR) United States $0.073B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.071B 0.00
Aevi Genomic Medicine (GNMX) United States $0.056B 0.00
Evoke Pharma (EVOK) United States $0.045B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.030B 0.00
Acasti Pharma (ACST) Canada $0.021B 0.00
Agile Therapeutics (AGRX) United States $0.017B 0.00